BiotechTube

Org 36286 (corifollitropin alfa)

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

In Vitro Fertilization

Conditions

In Vitro Fertilization

Trial Timeline

Dec 9, 2005 → Jul 11, 2007

NCT ID
NCT00702351

About Org 36286 (corifollitropin alfa)

Org 36286 (corifollitropin alfa) is a phase 2 stage product being developed by Organon for In Vitro Fertilization. The current trial status is completed. This product is registered under clinical trial identifier NCT00702351. Target conditions include In Vitro Fertilization.

What happened to similar drugs?

1 of 4 similar drugs in In Vitro Fertilization were approved

Approved (1) Terminated (1) Active (3)
🔄COL-1620 + Gonadotropin-releasing hormone (GnRH) analogue + Follicle-stimulating hormone (FSH) + Human Chorionic Gonadotropin (hCG)MerckPhase 3
✅Gonal -f® [r-hFSH] + Ovitrelle® [r-hCG alfa] + Gonadotropin-releasing hormone (GnRH) Agonist + Gonadotropin-releasing hormone (GnRH) AntagonistMerckApproved
🔄Corifollitropin alfa + RecFSH / Follitropin beta (Days 1 to 7) + Placebo Corifollitropin alfa + Placebo RecFSH / follitropin beta + RecFSH / Follitropin beta (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneOrganonPhase 3
🔄Corifollitropin alfa + FSH + GnRH antagonist + (rec)hCG + ProgesteroneOrganonPhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00702351Phase 2Completed

Competing Products

8 competing products in In Vitro Fertilization

See all competitors
ProductCompanyStageHype Score
COL-1620 + Gonadotropin-releasing hormone (GnRH) analogue + Follicle-stimulating hormone (FSH) + Human Chorionic Gonadotropin (hCG)MerckPhase 3
40
Gonal -f® [r-hFSH] + Ovitrelle® [r-hCG alfa] + Gonadotropin-releasing hormone (GnRH) Agonist + Gonadotropin-releasing hormone (GnRH) AntagonistMerckApproved
35
Follitropin betaOrganonPre-clinical
20
150 µg Corifollitropin Alfa + 200 IU RecFSH/Follitropin beta (Days 1 to 7) + Placebo for Corifollitropin Alfa + Placebo for RecFSH/Follitropin beta + 200 IU RecFSH/Follitropin beta (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneOrganonPre-clinical
20
Corifollitropin alfa + RecFSH / Follitropin beta (Days 1 to 7) + Placebo Corifollitropin alfa + Placebo RecFSH / follitropin beta + RecFSH / Follitropin beta (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneOrganonPhase 3
34
corifollitropin alfa + recFSH (follitropin alfa) + gonadatropin releasing hormone (GnRH) antagonist ganirelix + human chorion gonadatropin (hCG) + progesterone + placebo-recFSH (follitropin alfa) + placebo-corifollitropin alfa + open-label recFSHOrganonPre-clinical
20
OrgalutranOrganonPre-clinical
20
Corifollitropin alfa + FSH + GnRH antagonist + (rec)hCG + ProgesteroneOrganonPhase 3
34